Recent advances in animal models of diabetic nephropathy

Nephron - Experimental Nephrology

Volumn 126, Issue 4, 2014, Pages 191-195

  Betz, Boris ^a   Conway, Bryan R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Background strain; Diabetic nephropathy; Hypertension; Transcriptomic profiling

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LEPTIN; LEPTIN RECEPTOR;

ALBUMINURIA; ANIMAL MODEL; ARTERIOSCLEROSIS; DIABETIC NEPHROPATHY; DISEASE PREDISPOSITION; FVB MOUSE; GENE EXPRESSION; GLOMERULOSCLEROSIS; HYPERGLYCEMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REMISSION; REVIEW; TRANSCRIPTOMICS; BTBR MOUSE; C57BL 6 MOUSE; DB/DB MOUSE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; KIDNEY DISEASE; KNOCKOUT MOUSE; MOUSE MODEL; MOUSE STRAIN; OB/OB MOUSE; RAT MODEL; RODENT MODEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; DISEASE MODEL; GENETICS; METABOLISM; MOUSE; PATHOLOGY; RAT; SPECIES DIFFERENCE;

ANIMALS; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; HUMANS; MICE; RATS; SPECIES SPECIFICITY;

EID: 84904272582     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000363300     Document Type: Review

References (26)

1. System URD: USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012.
2. Brosius FC 3rd, Alpers CE, Bottinger EP, Breyer MD, Coffman TM, Gurley SB, et al: Mouse models of diabetic nephropathy. J Am Soc Nephrol 2009; 20: 2503-2512.
3. Brosius FC 3rd, Alpers CE: New targets for treatment of diabetic nephropathy: what we have learned from animal models. Curr Opin Nephrol Hypertens 2013; 22: 17-25.
4. Breyer MD, Bottinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW, et al: Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005; 16: 27-45.
5. Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, et al: Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes 2013; 62: 299-308.
6. Nakagawa T, Johnson RJ: Endothelial nitric oxide synthase. Contrib Nephrol 2011; 170: 93-101.
7. Zhao HJ, Wang S, Cheng H, Zhang MZ, Takahashi T, Fogo AB, et al: Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006; 17: 2664-2669.
8. Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, et al: Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550.
9. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637.
10. Chua S Jr, Li Y, Liu SM, Liu R, Chan KT, Martino J, et al: A susceptibility gene for kidney disease in an obese mouse model of type II diabetes maps to chromosome 8. Kidney Int 2010; 78: 453-462.
11. Yuzawa Y, Niki I, Kosugi T, Maruyama S, Yoshida F, Takeda M, et al: Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy. J Am Soc Nephrol 2008; 19: 1701-1711.
12. Zheng S, Huang Y, Yang L, Chen T, Xu J, Epstein PN: Uninephrectomy of diabetic OVE26 mice greatly accelerates albuminuria, fibrosis, inflammatory cell infiltration and changes in gene expression. Nephron Exp Nephrol 2011; 119:e21-e32.
13. Hudkins KL, Pichaiwong W, Wietecha T, Kowalewska J, Banas MC, Spencer MW, et al: BTBR Ob/Ob mutant mice model progressive diabetic nephropathy. J Am Soc Nephrol 2010; 21: 1533-1542.
14. Mogensen CE: Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction. BMJ 1998; 317: 693-694.
15. Roglic G, Colhoun HM, Stevens LK, Lemkes HH, Manes C, Fuller JH: Parental history of hypertension and parental history of diabetes and microvascular complications in insulindependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 1998; 15: 418-426.
16. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, et al: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 2002; 347: 797-805.
17. Berkman J, Rifkin H: Unilateral nodular diabetic glomerulosclerosis (Kimmelstiel-Wilson): report of a case. Metabolism 1973; 22: 715-722.
18. Beroniade VC, Lefebvre R, Falardeau P: Unilateral nodular diabetic glomerulosclerosis: recurrence of an experiment of nature. Am J Nephrol 1987; 7: 55-59.
19. Cooper ME, Allen TJ, Macmillan P, Bach L, Jerums G, Doyle AE: Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am J Hypertension 1988; 1: 5-10.
20. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 1998; 54: 343-352.
21. Janssen U, Riley SG, Vassiliadou A, Floege J, Phillips AO: Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int 2003; 63: 2162-2170.
22. Conway BR, Rennie J, Bailey MA, Dunbar DR, Manning JR, Bellamy CO, et al: Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy. J Am Soc Nephrol 2012; 23: 405-411.
23. Hartner A, Cordasic N, Klanke B, Wittmann M, Veelken R, Hilgers KF: Renal injury in streptozotocin-diabetic Ren2-transgenic rats is mainly dependent on hypertension, not on diabetes. Am J Physiol Renal Physiol 2007; 292:F820-F827.
24. Lindenmeyer MT, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, et al: Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol 2007; 18: 1765-1776.
25. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantations. New Engl J Med 1998; 339: 69-75.
26. Pichaiwong W, Hudkins KL, Wietecha T, Nguyen TQ, Tachaudomdach C, Li W, et al: Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol 2013; 24: 1088-1102.